Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 13
Original Research
A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,060 | Dovepress* | 10,418+ | 1,930 | 12,348 | |
| PubMed Central* | 642 | 219 | 861 | ||
| Totals | 11,060 | 2,149 | 13,209 | ||
| *Since 23 December 2016 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar